Device Industry Sees Surge in Trade Agreement, False Claims Litigation Post author:PacConAdmin Post published:May 15, 2023 Post category:Drug Industry Daily Part 1 of a two-part series on litigation trends in the medical device industry. Source: Drug Industry Daily You Might Also Like Roche Pulls Plug on Crenezumab After Another Alzheimer’s Disease Trial Disappointment June 16, 2022 FDA Final Guidance Includes Reporting Scenarios for Cell- and Tissue-Based Products September 6, 2017 UK’s NICE Rejects BioMarin’s Drug for Ultra-Rare Metabolic Disorder November 14, 2021
FDA Final Guidance Includes Reporting Scenarios for Cell- and Tissue-Based Products September 6, 2017